These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8686278)

  • 1. [Measles virus proteins, their function and antigenic variability].
    Khaĭder AM
    Vopr Virusol; 1996; 41(2):72-4. PubMed ID: 8686278
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological feasibility of measles eradication.
    Bellini WJ; Rota PA
    Virus Res; 2011 Dec; 162(1-2):72-9. PubMed ID: 21963661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constraints on the Genetic and Antigenic Variability of Measles Virus.
    Beaty SM; Lee B
    Viruses; 2016 Apr; 8(4):109. PubMed ID: 27110809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological mechanisms controlling measles virus infection.
    Cernescu C
    Virologie; 1981; 32(1):41-55. PubMed ID: 6171091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic characterization of hemagglutinin protein of measles viruses in Hokkaido district, Japan, 2006-2015.
    Miyoshi M; Komagome R; Yamaguchi H; Ishida S; Nagano H; Okano M
    Microbiol Immunol; 2018 Jun; 62(6):411-417. PubMed ID: 29687918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation: a mechanism of viral persistence.
    Fujinami RS; Oldstone MB
    Prog Brain Res; 1983; 59():105-11. PubMed ID: 6198676
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a panel of monoclonal antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea virus.
    Corapi WV; Donis RO; Dubovi EJ
    Am J Vet Res; 1990 Sep; 51(9):1388-94. PubMed ID: 2168687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
    Sullender WM; Edwards KG
    Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic characterization of measles and SSPE virus haemagglutinin by monoclonal antibodies.
    ter Meulen V; Löffler S; Carter MJ; Stephenson JR
    J Gen Virol; 1981 Dec; 57(Pt 2):357-64. PubMed ID: 6172558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.
    Sheshberadaran H; Norrby E; McCullough KC; Carpenter WC; Orvell C
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1381-92. PubMed ID: 2425047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of monoclonal antibodies directed against four structural components of canine distemper virus.
    Orvell C; Sheshberadaran H; Norrby E
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():443-56. PubMed ID: 2579191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of B cell epitopes in measles virus nucleocapsid protein.
    Zvirbliene A; Kucinskaite I; Sezaite I; Samuel D; Sasnauskas K
    Arch Virol; 2007 Jan; 152(1):25-39. PubMed ID: 16944047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
    de Swart RL; Yüksel S; Osterhaus AD
    J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
    Morita Y; Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():451-8. PubMed ID: 2448418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the neutralization capacity of different types of human measles virus vaccine and the epidemic strains].
    Feng Y; Lu YY; Yan JY; Jiang XH; Shi W; Xu CP; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1123-6. PubMed ID: 18396671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.
    Delmas B; Gelfi J; Laude H
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1405-18. PubMed ID: 2425049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.